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Abstract
Background: Causes of the rapidly increasing incidence of breast cancer in Middle East and Asian countries are
incompletely understood. We evaluated risk factors for postmenopausal breast cancer and estimated their
attributable fraction in Iran.
Methods: We performed a hospital-based case–control study, including 493 women, diagnosed with breast cancer
at 50 years or later between 2005–2008, and 493 controls. We used logistic regression models to estimate
multivariable odds ratios (OR) and 95% confidence intervals (CI), and population attributable fractions (PAF) for
significant risk factors.
Results: The risk of breast cancer decreased with increasing parity. Compared with nulliparous women, the
adjusted OR (95% CI) was 0.53 (0.25-1.15) for parity 1–3, 0.47 (0.29-0.93) for parity 4–6 and 0.23 (0.11-0.50) for parity
≥7. The estimated PAF for parity (<7) was 52%. The positive association between body mass index (BMI) and breast
cancer risk was confined to women diagnosed at 58 years or later. Compared with normal weight women (BMI
18.5-24.9), overweight (BMI 25–29.9) and obese (BMI ≥30) women were at increased risk of breast cancer diagnosed
at 58 years or later (ORs [95% CI] 1.27 [0.97-2.65] and 2.34 [1.33-4.14], respectively). The estimated PAF for obesity/
overweight (BMI >25) was approximately 25%. The family history was significantly associated with increased breast
cancer risk, but not increasing height, early age at menarche, late age at first birth or short breastfeeding.
Conclusions: Decreasing parity and increasing obesity are determinants of increasing breast cancer incidence
among Iranian women. These trends predict a continuing upward trend of postmenopausal breast cancer.
Keywords: Breast neoplasm, Postmenopausal, Middle East, Risk factor, Attributable fraction
Background
With an estimated 1.4 to 1.6 million new cases diagnosed
around the world in 2008, breast cancer is the most com-
mon cancer among women in high-and middle-income,
but also in a growing number of low-income countries
[1]. There is, however, still a considerable geographical
variation in incidence [2,3], especially with respect to
postmenopausal breast cancer [4]. Until recently, Middle
East and Asian countries had among the lowest rates of
breast cancer in the world [5], but the incidence has
increased rapidly during the past two decades [4,6,7].
This increase is expected to continue and breast cancer
mortality will almost double in the Middle East during
the coming decade, which is the highest worldwide
expected increase [5].
In Iran, the annual number of new breast cancer cases
is estimated to double from 2008 to 2030 due to the
demographic transition alone [8]. Current knowledge
about breast cancer etiology is primarily derived from
studies in high-income countries [9]. However, the wide
variety of lifestyle and environmental exposures in low-
and middle-income countries in transition might provide
novel information on breast cancer etiology [10]. In par-
ticular, Middle East, a large geographic area with a variety
of ethnic groups, is now undergoing a rapid transition in
lifestyle and reproductive patterns. For example, the aver-
age number of childbirths in Iran declined from over 7
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of relevant epidemiological data makes it difficult to
understand the reasons for the lower incidence of breast
cancer in the Middle East and Asia [13,14] compared
with western countries, and to estimate and interpret the
contribution of changing pattern of established risk fac-
tors in the recent rapidly increasing trend of breast can-
cer in these populations [10,14]. To this end, we
undertook a large case–control study in Iran to evaluate
some established risk factors of postmenopausal breast
cancer and their role in the rising trend of breast cancer
in Iran.
Methods
We performed a hospital-based case control study to
identify risk factors for postmenopausal breast cancer in
Iranian women. Cases were recruited from Motahari
Breast Clinic of Shiraz University of Medical Sciences.
This center collects data from about 80% of all incident
breast cancer patients treated in main hospitals of Shiraz
city, including general hospitals of Faghihi and Namazi
and private hospitals of Dena and Ordibehesht. Shiraz,
the capital city of Fars province, is located in the south-
ern part of Iran. Faghihi hospital is the major hospital
providing oncology services for breast cancer patients,
and more than 85% of newly diagnosed breast cancer
patients within the Fars province are referred to this
hospital for treatment. In addition, the Faghihi hospital
is also the referral center for other provinces in the
southern part of Iran, including Bushehr, Khuzestan,
Hormozgan and Kohgiluye & Boyer Ahmad. Women
with histopathologically confirmed breast cancer are re-
ferred to Motahari clinic for postoperative care and fol-
low-ups. Women with newly diagnosed breast cancer
are interviewed using a structured questionnaire that
contains questions about risk factors for breast cancer
and other reproductive cancers.
Eligible cases were women with an incident histo-
pathologically confirmed breast cancer, diagnosed at
50 years of age or older. Most patients (93%) were inter-
viewed within six months after diagnosis. All women
were interviewed between September 2005 and Decem-
ber 2008. We excluded five cases with missing informa-
tion on age and eleven case patients from other
provinces because we could not find any matched con-
trols for them.
Controls were frequency-matched with cases on five-
year age groups and province of residence. Controls
were primarily selected from healthy female visitors ac-
companying patients referred to the Faghihi hospital for
general surgery (60%), urology (24%) and cardiovascular
(16%) diseases. Controls did not have a history of breast
cancer at enrollment. For a small number of old case
patients (11%), for whom we could not find a healthy
control, we selected controls from patients referred to
urology, cardiovascular and general surgery wards for
conditions unrelated to known or likely risk factors for
breast cancer, like gynecologic, hormonal or neoplastic
diseases. A total of 487 potentially healthy visitor con-
trols and 98 patient controls were selected, but 49 (10%)
healthy women and 43 (44%) patients refused to partici-
pate. Finally, a total of 493 cases of postmenopausal
breast cancer and 493 controls were included in the
study.
Reliable information about age at menopause was not
available for the study subjects. When information on
menstrual history is not available, 50 years of age may be
the best proxy for all menses-based definitions of meno-
pause in western countries[15]. It has been shown that
the mean age of natural menopause among Iranian
women is approximately 48 years [16,17]. Therefore, we
used 50 years as a conservative cut point for defining
postmenopausal breast cancer.
Data collection
For both cases and controls, face-to-face interviews were
performed, using an identical structured questionnaire
to collect information on age, place of residence, marital
status, educational level, family history of breast cancer,
age at menarche, occupation, parity, past use of oral
contraceptives, age at first pregnancy and lifetime dur-
ation of breastfeeding. Cases were interviewed at their
first time of treatment between September 2005 and
December 2008. Controls were interviewed from May
2009 through August 2009. Interviews were conducted
by two trained female nurses (one for cases and one for
controls), and the time of interviews was similar for
cases and controls. Height and weight were measured at
the end of the interview. None of interviewers were
aware of the study hypotheses.
All included subjects were informed about the study
protocol and provided oral informed consent. The study
was approved by the Research Ethics Committee of
Shiraz University of Medical Sciences.
Exposure categorization
Information on parity was collected as a categorical vari-
able (0, 1–3, 4–6, ≥7), and therefore analyzed accord-
ingly. Information on age at menarche and age at first
childbirth was collected using categorical variables in the
questionnaire: < 12, 12–15 and >15 years for age at me-
narche; and <15, 15–24 and ≥25 years for age at first
childbirth. Education was categorized as illiterate, elem-
entary, high school and university degree. Occupation
was grouped as housewife and employed. Life time dur-
ation of breastfeeding was categorized as never and in
approximate tertiles based on the distribution among
controls (1–94, 95–162, and more than 162 months).
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ized as <12 months and ≥12 months. Oral contraceptive
use was categorized as never/ever, and (among ever
users) the duration of usage, categorized based on the
tertile values of the distribution among controls (1–48,
49–116, and more than 116 months). Height was cate-
gorized based on its approximate quartile cut-off points
of the distribution among controls (≤151, 152–156, 157–
160 and >160 cm). BMI was calculated as weight (kg)
divided by height squared (m
2) and categorized as <18.5,
18.5-24.9, 25–29.9 and ≥30 kg/m
2.
Statistical analyses
We used unconditional logistic regression with adjust-
ment for the matching factors (age and residential place)
to estimate the odds ratios (ORs) and 95% confidence
intervals (CI). We used univariable analyses to estimate
the crude ORs and 95% CI. Multivariable logistic regres-
sion models were fitted to estimate the association be-
tween each independent variable and postmenopausal
breast cancer while adjusting for other potential con-
founding variables. Additional analyses were performed
on data restricted to parous women (n=936). The mod-
els for these analyses were stratified for categories of
parity.
To examine the hypothesis that the obesity-related risk
is smaller among perimenopausal or recently postmeno-
pausal women than among elderly women, we also con-
ducted analyses stratified by the mean of age of breast
cancer (less than 58 years and 58 years or older). We
assessed significance of interaction using Wald test sta-
tistics. We also computed adjusted population attribut-
able fractions and 95% confidence intervals for
significant variables (parity, BMI, family history of breast
cancer and oral contraceptive use) as described by
Greenland and Drescher [9], using aflogit module devel-
oped for Stata. All P values were 2-sided. All analyses
were conducted using Stata 11.0 software (Stata Corpor-
ation, College Station, TX).
Results
The mean age of the 493 women diagnosed with post-
menopausal breast cancer was 58.2 (±7.2 standard devi-
ation [SD], median=56, range: 50 – 89) and 58.0 (±7.4
SD, median=56, range: 50 – 88) among the 493
frequency-matched controls. As depicted in Table 1,
illiteracy rates were 70% among cases and 79% among
controls with parity 7 and higher. Corresponding rates
among women with parity 1 to 3 were 19% among cases
and 30% among controls. While 45% of cases and 29%
of controls with parity 1–3 were employed, only 1% of
both cases and controls with parity 7 or higher were
employed. Moreover, obesity (BMI ≥30) was generally
more prevalent among those with lower parity. Table 2
shows that the distribution of parity and literacy rates
among the controls mirror those reported from general
female population in the 2006 census in the Fars
Province, and are also similar to overall rates in Iran [18].
Compared with nulliparous women, parous women
had a reduced risk of postmenopausal breast cancer in
both univariable and multivariable analyses (Table 3).
The risk of breast cancer decreased with increasing par-
ity. Compared with nulliparous women, women with 1–
3a n d4 –6 childbirths had a 47 and 53% reduction in
risk, while risk was reduced by 77% in women with at
least 7 childbirths (OR=0.23). Risk of postmenopausal
breast cancer increased significantly with educational
level in the univariable, but not in the multivariable ana-
lyses. This change in risk estimate was primarily due to
confounding by parity; when we only adjusted for parity,
we obtained similar risk estimates for education as those
presented in the adjusted analysis in Table 3 (data not
shown).
BMI revealed a significant linear association with
breast cancer risk (P-trend=0.01). Compared with nor-
mal weight women (BMI 18.5-24.9), overweight (BMI
25.0-29.9), and obese women (BMI ≥30) had, in the un-
adjusted and adjusted analyses, approximately a 40% and
a 60% increased risk of breast cancer, respectively. In the
association between BMI and breast cancer, parity was a
weak positive confounder and only adjusting for parity
slightly attenuated the OR related to overweight (OR=
1.39, 95% CI 1.02 – 1.94) but not obesity (OR=1.61,
95% CI 1.18 – 2.30). In analyses stratified by the mean
age of breast cancer (less than 58 years and 58 years or
more), the positive association between BMI and breast
cancer was restricted to women aged 58 or older. How-
ever, the (multiplicative) interaction term between BMI
and age was not significant (Table 3). Family history of
breast cancer was associated with increased risks of
postmenopausal breast cancer. There was no linear asso-
ciation between age at menarche and risk of postmeno-
pausal breast cancer (P for trend 0.09). Mean height for
cases and controls were 154.8 cm (SD=6.2) and
155.8 cm (SD=6.3), respectively, but height did not in-
fluence risk of breast cancer in the adjusted analysis.
To further investigate the parity-related reduced breast
cancer risk, we investigated effects of reproductive fac-
tors in parous women (Table 4). Compared to women
with 1–3 births, risk of breast cancer was reduced
among women with 4–6 births (OR=0.74 CI: 0.50 –
1.09) and 7 or more births (OR=0.30 CI: 0.20 – 0.47).
Cases were more likely to have their first childbirth at
25 years or later, but in multivariable analysis we found
no significant association between age at first childbirth
and risk of postmenopausal breast cancer. In the univari-
able analysis, lifetime duration of breastfeeding showed a
negative linear association with risk of breast cancer and
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decreased risk of postmenopausal breast cancer (P for
trend<0.001). However, in multivariable analysis, breast-
feeding was no longer associated with risk of breast can-
cer. We also examined the average months of
breastfeeding per child, which was not associated with
breast cancer risk (Table 4). Compared with women
never used oral contraceptives, women who ever used
were at a higher risk of breast cancer. The association
between oral contraceptive use and breast cancer risk
was strengthened in the adjusted analysis, but there was
no dose response relationship between length of oral
contraceptive use and breast cancer risk.
Population attributable fractions for statistically signifi-
cant risk factors in the multivariable logistic models and
combination of them are shown in Table 5. Parity less
than 7 children and overweight/obesity (BMI>25)
Table 1 Distribution of cases and controls participated in the study in Southern Iran according to selected variables by
parity
Parity
Nulliparous 1-3 4-6 7+
Cases Controls Cases Controls Cases Controls Cases Controls
(n=38) (n=12) (n=130) (n=76) (n=227) (n=197) (n=98) (n=208)
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Age at menarche (years)
< 12 7 (18) 0 (0) 15 (12) 6 (8) 17 (7) 5 (2) 3 (3) 14 (7)
12 – 15 26 (69) 11 (92) 98 (75) 66 (87) 188 (83) 169 (86) 83 (85) 179 (86)
>15 5 (13) 1 (8) 17 (13) 4 (5) 22 (10) 23 (12) 12 (12) 15 (7)
Education
None 15 (39) 6 (50) 24 (19) 23 (30) 71 (31) 99 (50) 69 (70) 164 (79)
Elementary 6 (16) 2 (17) 21 (16) 12 (16) 102 (45) 69 (35) 26 (27) 40 (19)
High school 5 (13) 4 (33) 56 (43) 27 (36) 44 (20) 27 (14) 3 (3) 4 (2)
University 12 (32) 0 (0) 29 (22) 14 (18) 10 (4) 2 (1) 0 (0) 0 (0)
Occupation
Housewife 20 (53) 10 (83) 72 (55) 54 (71) 202 (89) 192 (97) 97(99) 206 (99)
Employed 18 (47) 2 (17) 58 (45) 22 (29) 25 (11) 5 (3) 1 (1) 2 (1)
Height (cm)
<152 11 (29) 8 (67) 40 (31) 16 (21) 56 (25) 49 (25) 36 (37) 59 (28)
152 – 156 14 (37) 2 (17) 36 (28) 18 (24) 85 (37) 49 (25) 25 (26) 53 (26)
157 – 160 7 (18) 1 (8) 25 (19) 25 (33) 43 (19) 67 (34) 15 (15) 70 (34)
>160 4 (11) 1 (8) 24 (18) 17 (22) 39 (17) 32 (16) 18 (18) 26 (12)
Missing 2 (5) 0 (0) 5 (4) 0 (0) 4 (2) 0 (0) 4 (4) 0 (0)
BMI
<18.5 0 (0) 0 (0) 0 (0) 2 (3) 1 (0) 5 (3) 3 (3) 7 (3)
18.5 – 24.9 11 (29) 5 (42) 37 (28) 22 (29) 50 (22) 69 (35) 27 (28) 77 (34)
25 – 29.9 19 (50) 7 (58) 52 (40) 30 (39) 97 (43) 77 (39) 40 (41) 79 (38)
≥30 6 (16) 0 (0) 36 (28) 22 (29) 75 (33) 46 (23) 24 (24) 51 (25)
Missing 2 (5) 0 (0) 5 (4) 0 (0) 4 (2) 0 (0) 4 (4) 0 (0)
Table 2 Distribution of selected population indicators in
Iran, Fars Province and control group in the present
study
Indicator Iran
1 Fars Province
1 Present Study
Average number of childbirths per woman
50 – 54 years 5.42 5.63 5.61
55 – 59 years 5.93 6.06 6.02
60 – 64 years 6.18 6.16 6.27
65+ 6.11 6.03 6.57
Female literacy rate
Total (6 years and older) 84.6 86.6 -
50 – 64 years 41.2 44.8 44.9
65+ 16.1 16.9 21.2
Urbanization 68.4 61.1 59.6
1According to the 2006 census [16].
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postmenopausal women, respectively. The estimated at-
tributable fraction combined for all significant risk fac-
tors including parity (< 7), BMI (> 25), family history of
breast cancer and oral contraceptive usage was 71%.
Discussion
In this hospital-based case–control study of Iranian
women, multiparity was a strong protective factor for
postmenopausal breast cancer. Family history of breast
cancer, oral contraceptive use and increasing BMI were
associated with increased risks of postmenopausal breast
cancer, while there were no significant associations with
age at menarche, age at first childbearing, height, educa-
tion and breastfeeding. The estimated attributable frac-
tion combined for parity less than 7 children and
overweight/obesity (BMI>25) accounted for approxi-
mately 64% of breast cancer among postmenopausal
women in Iran.
To the best of our knowledge, this is the largest case–
control study of postmenopausal breast cancer in Iran.
Nonetheless, our study has some important limitations.
Hospital-based case–control studies are particularly sus-
ceptible to selection bias [19]. We are confident that our
case-women were representative for all incident breast
cancers in our study area. However, because population-
based sampling of controls is not feasible in Iran, we had
to rely on less optimal approaches for control selection.
Although the indicators shown in Table 2 are reassuring,
there is no mechanism whereby we can document that
Table 3 Crude and adjusted odds ratios (OR) and 95%
confidence intervals (CI) of the 493 cases and 493
controls in the study in Southern Iran
Parameter Events Crude OR
(95% CI)
Adjusted OR
(95%CI)
1
Cases/Controls
Parity
Nulliparous 38/12 1 1
1 – 3 130/76 0.50 (0.25 – 1.02) 0.53 (0.25 – 1.15)
4 – 6 227/197 0.34 (0.17 – 0.67) 0.47 (0.29 – 0.93)
7+ 98/208 0.14 (0.07 – 0.28) 0.23 (0.11 – 0.50)
P for trend < 0.001 < 0.001
Age at menarche (years)
< 12 42/25 1.80(1.07 – 3.02) 1.72 (0.96 – 3.07)
12 – 15 395/425 1 1
> 15 56/43 1.40 (0.91 – 2.13) 1.11 (0.86 – 2.24)
P for trend 0.75 0.09
Education
None 179/292 1 1
Elementary 155/123 2.05 (1.51 – 2.79) 1.33 (0.83 – 2.29)
High school 108/62 2.84 (1.95 – 4.12) 1.26 (0.78 – 2.03)
University 51/16 5.19 (2.81 – 9.59) 1.50 (0.64 – 3.48)
P for trend < 0.001 0.06
Occupation
Housewife 391/462 1 1
Employed 102/31 3.88 (2.51 – 5.99) 2.05 (1.15 – 3.92)
Height (cm)
2
≤ 151 143/132 1 1
152 – 156 160/122 1.21(0.86 – 1.69) 1.12 (0.77 – 1.62)
157 – 160 90/163 0.50(0.35 – 0.72) 0.73 (0.49 – 1.71)
> 160 85/76 1.03(0.69 – 1.52) 1.08 (0.69 – 1.66)
Missing 15/0
P for trend 0.06 0.10
BMI (Overall)
< 18.5 4/14 0.38 (0.12 – 1.19) 0.60 (0.17 – 2.11)
18.5 – 24.9 129/181 1 1
25 – 29.9 208/193 1.43 (1.06 – 1.95) 1.39 (1.02 – 1.94)
≥ 30 141/119 1.58 (1.12 – 2.22) 1.61 (1.18 – 2.30)
Missing 15/0
P for trend <0.001 0.01
BMI (age <58 years)
< 18.5 4/5 0.90 (0.23 – 3.55) -
18.5 – 24.9 78/90 1 1
25 – 29.9 126/123 1.18 (0.79 – 1.74) 1.27 (0.80 – 2.02)
≥ 30 89/82 1.25(0.81 – 1.91) 1.21 (0.73 – 1.99)
P for trend 0.30 0.47
Table 3 Crude and adjusted odds ratios (OR) and 95%
confidence intervals (CI) of the 493 cases and 493
controls in the study in Southern Iran (Continued)
BMI (age ≥58 years)
< 18.5 0/9 - -
18.5 – 24.9 47/77 1 1
25 – 29.9 82/70 1.91 (1.18 – 3.11) 1.56 (0.97 – 2.65)
≥ 30 52/37 2.30 (1.32 – 4.01) 2.34 (1.33 – 4.14)
P for trend 0.002 0.008
P for interaction
3 0.16 0.09
F.H. of breast cancer
No 422/470 1 1
Yes 71/23 3.50 (2.37 – 5.17) 2.61 (1.72 – 3.96)
1
st relative 43/15 3.19(1.73 – 5.86) 2.13 (1.20 – 4.46)
2
nd relative 28/8 3.89(1.74 – 8.69) 1.98 (0.96 – 5.62)
P for trend < 0.001 0.003
(Abbreviation F.H.: Family History).
1Adjusted for all variables in the table in addition to age.
2Height was categorized based on approximate quartile values of the control
population.
3Multiplicative interaction between BMI and age.
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lence of risk factors in the person-time that gave rise to
our cases. Differential misclassification of exposure is
another possible limitation. Such misclassification could
arise both because cases and controls were interviewed
by different nurses and because they recall or report dif-
ferently. Reassuringly, however, our main findings were
related to measured height and weight and to number of
children, arguably factors with little opportunity for
misclassification. Hence, we feel confident that the
strong associations we found in relation to BMI and par-
ity cannot possibly have arisen due to differential mis-
classification. In addition, we did not collect information
about hormone replacement therapy (HRT), an estab-
lished risk factor for breast cancer [9]. However, similar
to many Asian countries [20,21], less than one per cent
of Iranian women aged 50 years and older used HRT,
often following surgical menopause [22]. Thus, HRT is
an unlikely confounder in our study. Previous studies fo-
cusing on the association between parity and breast can-
cer have primarily been conducted in high-risk western
countries among women with generally low parity and
therefore limited possibilities to explore the association
between parity and breast cancer in detail. A
population-based study in Finland found that women
with at least five births had a significantly decreased risk
of breast cancer (SIR=0.55), especially postmenopausal
breast cancer [23], and a similar reduction in risk was
reported for women with at least seven childbirths in
Nigeria [24]. In our study, the protective effect of
women with at least 7 childbirths was even stronger
than the risk reductions reported from Finland and
Nigeria. Socio-cultural differences may partly account
for the differences of the parity-related reduced breast
cancer risk between study populations.
We found that the grand multiparous women differed
from those with fewer childbirths; they were less edu-
cated, had a younger age at first pregnancy, breastfed
their children for longer periods and were less likely to
use oral contraceptives. We find it likely that the pro-
tective effect of grand multiparity can to a large extent
be explained by unmeasured lifestyle factors, which dis-
tort the association away from the null and strengthened
it. For example, differences between women with high
and low parity with respect to exposures to traditional
low calorie high fiber diets, physical activity due to trad-
itional way of life, early life events and conditions may
play a role for the breast cancer risk in parous women
Table 4 Crude and adjusted odds ratios (OR) and 95%
confidence intervals (95% CI) for postmenopausal breast
cancer risk factors among parous women
Variable Events Crude OR Adjusted OR
1
Case/control (95%CI) (95%CI)
Parity
Overall 455/481
1 – 3 130/76 1 1
4 – 6 227/197 0.67 (0.47 – 0.94) 0.74 (0.50 – 1.09)
7+ 98/208 0.27 (0.19 – 0.39) 0.30 (0.20 – 0.47)
P for trend < 0.001 < 0.001
Age at first childbirth
Overall 454/481
<15 41/56 0.87 (0.56 – 1.34) 0.55 (0.28 – 1.10)
15 - 24 318/381 1 1
≥ 25 95/44 2.57 (1.75 – 3.79) 1.24 (0.40 – 3.80)
P for trend < 0.001 0.77
Breastfeeding (months)
Overall 454/481
Never 21/20 0.63 (0.33 – 1.20) 0.93 (0.29 – 1.86)
1 – 94 268/162 1 1
95 – 162 131/149 0.53 (0.39 – 0.72) 0.87 (0.27 – 2.78)
> 162 34/150 0.13 (0.08 – 0.21) 0.32 (0.08 – 1.22)
P for trend < 0.001 0.30
Breastfeeding per child
Overall 454/479
Never 21/20 0.91 (0.47 – 1.78) 0.98 (0.71 – 1.35)
< 12 months 125/110 1 1
≥ 12 months 308/349 0.77 (0.57 – 1.04) 0.92 (0.45 – 1.88)
P for trend 0.20 0.68
OCP usage (months)
Overall 454/481
Never 178/236 1 1
1 – 48 135/90 1.50 (1.15 – 1.95) 1.99 (1.03 – 3.83)
49 – 116 73/73 1.98 (1.42 – 2.77) 2.25 (1.12 – 4.49)
> 116 68/82 1.32 (0.90 – 1.93) 1.40 (0.66 – 2.99)
P for trend 0.36 0.10
1Adjusted for all variables in the table in addition to age, age at menarche,
education, BMI and family history of breast cancer.
Table 5 Percent population attributable fraction (PAF)
1
and 95% confidence intervals (CI) according to significant
variables and their combination
PAF (95% CI)
2
Parity (< 7) 52.6 (41.2 – 61.8)
BMI (> 25) 24.8 (8.3 – 38.3)
Parity+BMI 64.2 (52.1 – 73.2)
Family history of breast cancer (FH) 15.7 (10.6 – 20.5)
Oral contraceptive usage (OC) 13.7 (0.3 – 25.3)
Parity+BMI+FH+OC 71.3 (63.1 – 80.7)
1 The PAFs denote the proportion of an outcome in the population that would
be prevented if the exposure were completely removed assuming the
association was causal and all confounding accounted for.
2 Derived from multivariable logistic regression model.
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ian women with high and low parity may provide im-
portant clues with respect to prevention of late onset
breast cancer.
In most studies, the association between parity and
breast cancer risk is modified by age at first pregnancy.
MacMahon et al. discovered that younger age at first
childbearing reduces the risk of breast cancer [26]. This
association is biologically plausible and has also been
demonstrated in experimental rodent models [27]. The
protective effect of age at first full-term pregnancy might
be stronger for premenopausal than postmenopausal
breast cancer [28]. Some epidemiological studies have,
however, failed to reveal any relationship between breast
cancer and age at first full-term pregnancy independent
of parity [24,29]. We found no independent association
between age at first childbirth and breast cancer. In the
present study age at first pregnancy was in a lower range
than in most other studies. For example, 90 percent of
our controls had their first pregnancy before 25 years of
age compared with 35 and 68 percent respectively in
studies in the US [26] and New Zealand [29].
We found no significant association between breast-
feeding and risk of postmenopausal breast cancer.
Results of a collaborative study, combining epidemio-
logical data from 47 studies, found a protective role of
breastfeeding on the risk of breast cancer [30]. However,
a meta-analysis [31] and several studies [32-34] have
shown that the weak protective effect of lactation is con-
fined to premenopausal breast cancer. In our previous
study of premenopausal breast cancer in Iranian women,
we found a protective effect of breast feeding [35].
We found no significant association between educa-
tion and breast cancer after adjusting for other variables
in multivariable analysis. In Iran, womens’ literacy rates
increased from 57% to 97% between 1966 and 1996 in
urban areas, while corresponding increase in rural areas
was even more dramatic (from 5% to 86%) [36]. In 1998,
52% of students admitted to the governmental univer-
sities were women, which increased to 65% in 2007 [36].
Although education may have not directly affected
breast cancer in Iran, the dramatic increasing rate of
educated women is related to postponed marriage and
childbearing, more oral contraceptive use and lower
parity [12,37].
The positive association between BMI and risk of post-
menopausal breast cancer in our study is consistent with
the results of other studies in high-risk and low-risk
countries[38-40]. In stratified analysis, we also found
that this association was restricted to older women,
while there was no significant association between BMI
and breast cancer diagnosed below 58 years. A recent
national survey revealed that 67% of Iranian women in
the age group 55 to 64 years are overweight or obese
(BMI≥25) [41]. Among women aged 55 to 64 years, the
prevalence of overweight and obesity was 64% among
controls and 75% among cases (data not shown). In the
report of International Obesity Task Force, Middle East
has one of the highest prevalence rates of obesity in the
world [42]. Hence, along with aging of the population,
obesity will play a growing role in the burden of postme-
nopausal breast cancer in Iran and other Middle Eastern
countries the coming decades. The present study
showed that about 25% of postmenopausal breast can-
cers in Iran could be prevented if all women had
BMI≤25.
Iran experienced a high fertility rate until the 1980s
[36]. In 1980, the total fertility rate was about seven chil-
dren per women, which decreased to 2.8 children per
woman in 1996 and 1.7 in 2007 [36,37]. It is estimated
that, with assuming consistency of age-specific rates,
Iran will, only due to the demographic transition, face a
doubling in the number of new cases of breast cancer in
2030 [8]. However, this study indicates that 64% of post-
menopausal breast cancer in Iran could be attributed to
parity lower than 7 births and overweight/obesity (BMI>
25). Thus, with current decline in parity, increasing
prevalence of obesity and social changes toward
westernization, it is clear that due to increasing age-
specific incidence we may expect an even more rapid
growth, especially in postmenopausal women. Such
trends may also be expected in other Middle Eastern
and Asian countries with similar pattern of socio-
cultural and demographic transitions. In addition to
demographic differences, the declining parity in younger
birth cohorts may also explain the current ten years
lower mean age at onset of breast cancer in low- and
middle-income countries compared with high-income
countries [13,43-45].
Conclusions
In summary, low parity and obesity were the main risk
factors among postmenopausal women. The estimated
attributable fraction combined for parity less than 7 chil-
dren and overweight/obesity (BMI>25) accounted for
approximately 64% of breast cancer among postmeno-
pausal women in Iran. We predict a birth cohort effect
with an uprising trend in incidence rate of breast cancer
in Iran and many other Middle Eastern countries in the
near future.
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